08.01.2014 Views

PDF file - Department of Health and Ageing

PDF file - Department of Health and Ageing

PDF file - Department of Health and Ageing

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Annual report National Notifiable Diseases Surveillance System, 2004<br />

MVEV <strong>and</strong> KUNV for the Alice Springs region <strong>and</strong><br />

other regions in January 2004, <strong>and</strong> for the Top End in<br />

March 2004 after sentinel chicken seroconversions in<br />

the Leanyer swamp area near Darwin, <strong>and</strong> in April for<br />

the whole <strong>of</strong> the Northern Territory after notification <strong>of</strong><br />

the MVEV case.<br />

Kunjin virus<br />

Case defi nition – Kunjin virus<br />

Only confirmed cases are reported.<br />

Confirmed case: Requires isolation <strong>of</strong><br />

Kunjin virus, OR detection <strong>of</strong> Kunjin virus by<br />

nucleic acid testing, OR IgG seroconversion<br />

or a signifi cant increase in antibody level or a<br />

fourfold or greater rise in titre to Kunjin virus,<br />

OR detection <strong>of</strong> Kunjin virus-specifi c IgM in<br />

cerebrospinal fl uid, OR detection <strong>of</strong> Kunjin<br />

virus-specifi c IgM in serum in the absence <strong>of</strong><br />

IgM to Murray Valley encephalitis, Japanese<br />

encephalitis or dengue viruses. This is only<br />

accepted as laboratory evidence for encephalitic<br />

illnesses.<br />

AND Non-encephalitic disease: acute febrile<br />

illness with headache, myalgia <strong>and</strong>/or rash,<br />

OR encephalitic disease: acute febrile meningoencephalitis<br />

characterised by one or more <strong>of</strong><br />

the following: 1. focal neurological disease or<br />

clearly impaired level <strong>of</strong> consciousness, 2. an<br />

abnormal computerised tomograph or magnetic<br />

resonance image or electrocardiograph, 3.<br />

presence <strong>of</strong> pleocytosis in cerebrospinal fl uid,<br />

OR asymptomatic disease: case detected as<br />

part <strong>of</strong> a serosurvey should not be notifi ed.<br />

Confi rmation <strong>of</strong> laboratory result by a second<br />

arbovirus reference laboratory is required if the<br />

case occurs in areas <strong>of</strong> Australia not known to<br />

have established enzootic/endemic activity or<br />

regular epidemic activity.<br />

There were 12 notifi cations <strong>of</strong> KUNV during 2004,<br />

with 11 <strong>of</strong> the cases reported from Queensl<strong>and</strong>.<br />

These 11 cases were symptomatic with a mild febrile<br />

illness but without encephalitis. Of the 11 cases, nine<br />

were reported in January <strong>and</strong> February 2004 <strong>and</strong> it<br />

is likely that these cases were identifi ed because <strong>of</strong><br />

increased testing undertaken in north Queensl<strong>and</strong><br />

due to the major dengue outbreak (Jeffrey Hanna,<br />

personal communication). There is nothing to indicate<br />

any genuine increase in human health risk from<br />

Kunjin virus activity during that time.<br />

The other jurisdiction to report a KUNV notifi cation<br />

in 2004 was Victoria. In October 2004, a 35-year-old<br />

female was notifi ed as having acquired KUNV infection.<br />

The person lived in metropolitan Melbourne,<br />

but a detailed investigation did not reveal any likely<br />

exposure within Victoria, nor was there any other<br />

evidence <strong>of</strong> KUNV activity. She had travelled extensively<br />

overseas <strong>and</strong> it is assumed that she acquired<br />

KUNV or a closely-related virus while overseas.<br />

Dengue virus infection<br />

Case defi nition – dengue virus<br />

Only confirmed cases are reported.<br />

Confirmed case: Requires isolation <strong>of</strong><br />

dengue virus, OR detection <strong>of</strong> dengue virus by<br />

nucleic acid testing, OR IgG seroconversion<br />

or a signifi cant increase in antibody level or a<br />

fourfold or greater rise in titre to dengue virus,<br />

proven by neutralisation or another specifi c<br />

test, OR detection <strong>of</strong> dengue virus-specifi c<br />

IgM in cerebrospinal fl uid, in the absence <strong>of</strong><br />

IgM to Murray Valley encephalitis, Kunjin, or<br />

Japanese encephalitis viruses, OR detection<br />

<strong>of</strong> dengue virus-specifi c IgM in serum, except<br />

in North Queensl<strong>and</strong>. In North Queensl<strong>and</strong>,<br />

dengue virus-specifi c IgM in serum is acceptable<br />

evidence ONLY when this occurs during a<br />

proven outbreak.<br />

AND A clinically compatible illness (e.g. fever,<br />

headache, arthralgia, myalgia, rash, nausea,<br />

<strong>and</strong> vomiting, with a possible progression to<br />

dengue haemorrhagic fever, dengue shock<br />

syndrome or meningoencephalitis).<br />

Confi rmation <strong>of</strong> laboratory result by a second<br />

arbovirus reference laboratory is required if<br />

the case occurs in previously unaffected areas<br />

<strong>of</strong> Australia. Currently North Queensl<strong>and</strong> is<br />

the only area with the potential for indigenous<br />

(epidemic) dengue virus in Australia.<br />

58 CDI Vol 30 No 1 2006

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!